KIF18A-INHIBITOREN

Patent europeic · EP3897852 · En vigur

Inscripziun en il register

Numer da publicaziun: EP3897852
Numer da la dumonda: EP19842520
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: En vigur
Scrittira da patent: Concedì
Annunzià: 20-12-2019
Publitgà: 27-10-2021
Concedì: 22-07-2026
La protecziun finescha il pli tard: 19-12-2039
Proxima taxa annuala scadenta: 31-12-2026
Classas IPC: A61P 35/00 (2006.01)
C07D 401/12 (2006.01)
C07D 401/14 (2006.01)
C07D 405/14 (2006.01)
C07D 413/14 (2006.01)
A61K 31/506 (2006.01)
C07D 419/14 (2006.01)
C07D 491/044 (2006.01)
Prioritad: US 201862783061 P 20.12.2018
Dumonda PCT: PCT/US2019/068169 20.12.2019
Publicaziun PCT: WO2020/132648 25.06.2020
Lingua da l’annunzia: englais
Funtauna: Swissreg

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

02-09-2026
Represchentant inscrit
Representative
Murgitroyd & Company, Geneva Rhone 8 Sàrl, Rue du Commerce 4, 1204 Genève
Published in Swissreg on 02.09.2026
22-07-2026
Concedì
Specification status
Non-published patent application → Granted patent
Status of protective title
Initiated → Active
Published in Swissreg on 22.07.2026

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US

Geneva Rhone 8 Sàrl Rue du Commerce 4, 1204 Genève